111 related articles for article (PubMed ID: 2708552)
1. Effect of a high-fat meal on the bioavailability of a polymer-coated erythromycin particle tablet formulation.
Randinitis EJ; Sedman AJ; Welling PG; Kinkel AW
J Clin Pharmacol; 1989 Jan; 29(1):79-84. PubMed ID: 2708552
[TBL] [Abstract][Full Text] [Related]
2. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
3. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
Henney HR; Shah J
Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
[TBL] [Abstract][Full Text] [Related]
4. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
Bramer SL; Forbes WP
Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal behavior of orally administered radiolabeled erythromycin pellets in man as determined by gamma scintigraphy.
Digenis GA; Sandefer EP; Parr AF; Beihn R; McClain C; Scheinthal BM; Ghebre-Sellassie I; Iyer U; Nesbitt RU; Randinitis E
J Clin Pharmacol; 1990 Jul; 30(7):621-31. PubMed ID: 2391393
[TBL] [Abstract][Full Text] [Related]
7. The Lidose hard capsule formulation of fenofibrate is suprabioavailable compared to the nanoparticle tablet formulation under high-fat fed conditions.
Verbeeck RK; De Niet S; Lebrun S; Tremege M; Rennie TW; Coffiner M; Streel B; Cahay B
J Pharm Pharm Sci; 2015; 18(1):61-7. PubMed ID: 25877442
[TBL] [Abstract][Full Text] [Related]
8. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
[TBL] [Abstract][Full Text] [Related]
9. Effect of Low- and High-Fat Meals on the Pharmacokinetics of Venetoclax, a Selective First-in-Class BCL-2 Inhibitor.
Salem AH; Agarwal SK; Dunbar M; Nuthalapati S; Chien D; Freise KJ; Wong SL
J Clin Pharmacol; 2016 Nov; 56(11):1355-1361. PubMed ID: 27029823
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
11. Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and women.
Teo SK; Scheffler MR; Kook KA; Tracewell WG; Colburn WA; Stirling DI; Thomas SD
Biopharm Drug Dispos; 2000 Jan; 21(1):33-40. PubMed ID: 11038436
[TBL] [Abstract][Full Text] [Related]
12. Effect of food on the oral bioavailability of didanosine from encapsulated enteric-coated beads.
Damle BD; Yan JH; Behr D; O'Mara E; Nichola P; Kaul S; Knupp C
J Clin Pharmacol; 2002 Apr; 42(4):419-27. PubMed ID: 11936567
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effects of formulation and food on the pharmacokinetics of lenvatinib (E7080) in healthy volunteers.
Shumaker R; Aluri J; Fan J; Martinez G; Ren M; Chen K
Int J Clin Pharmacol Ther; 2014 Apr; 52(4):284-91. PubMed ID: 24548978
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of a controlled-release cyclobenzaprine tablet and influence of a high fat meal on bioavailability.
Gai MN; Costa E; Arancibia A
Int J Clin Pharmacol Ther; 2009 Apr; 47(4):269-74. PubMed ID: 19356393
[TBL] [Abstract][Full Text] [Related]
15. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
Ahmad M; Pervaiz F
Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of omeprazole 20 mg capsules containing omeprazole 22.5% enteric coated pellets versus a reference product in healthy Bangladeshi male subjects: an open-label, single-dose, randomized-sequence, two-way crossover study.
Islam MS; Trini AB; Shohag H; Ahmed MU; Maruf AA; Hasnat A
Int J Clin Pharmacol Ther; 2011 Dec; 49(12):778-86. PubMed ID: 22122821
[TBL] [Abstract][Full Text] [Related]
17. Effect of food on the bioavailability of adinazolam from a sustained release formulation: effect of meal timing and lack of dose dumping.
Fleishaker JC; Phillips JP; Lau HS
Biopharm Drug Dispos; 1990 Nov; 11(8):715-27. PubMed ID: 2271747
[TBL] [Abstract][Full Text] [Related]
18. Effect of three different diets on the bioavailability of a sustained release lithium carbonate matrix tablet.
Gai MN; Thielemann AM; Arancibia A
Int J Clin Pharmacol Ther; 2000 Jun; 38(6):320-6. PubMed ID: 10890582
[TBL] [Abstract][Full Text] [Related]
19. Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults.
Courtney R; Wexler D; Radwanski E; Lim J; Laughlin M
Br J Clin Pharmacol; 2004 Feb; 57(2):218-22. PubMed ID: 14748822
[TBL] [Abstract][Full Text] [Related]
20. A randomized, open-label, 5-period, balanced crossover study to evaluate the relative bioavailability of eltrombopag powder for oral suspension (PfOS) and tablet formulations and the effect of a high-calcium meal on eltrombopag pharmacokinetics when administered with or 2 hours before or after PfOS.
Wire MB; Bruce J; Gauvin J; Pendry CJ; McGuire S; Qian Y; Brainsky A
Clin Ther; 2012 Mar; 34(3):699-709. PubMed ID: 22336488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
